Parnell Pharmaceuticals Holdings Ltd
PARN
PARN was delisted on the 30th of December, 2016.
4 hedge funds and large institutions have $4.76M invested in Parnell Pharmaceuticals Holdings Ltd in 2014 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AWMDMG
1
Austin W. Marxe & David M. Greenhouse
New York
| $2.14M | +$2.39M | +310,616 | New |
|
2
Alyeska Investment Group
Chicago,
Illinois
| $1.43M | +$1.59M | +206,683 | New |
|
|
DCM
3
Driehaus Capital Management
Chicago,
Illinois
| $688K | +$766K | +99,663 | New |
|
|
PRCM
4
Pine River Capital Management
Minnetonka,
Minnesota
| $508K | +$566K | +73,653 | New |
|
PARN Hedge Fund Activity: Q2 2014 in Review
4 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Parnell Pharmaceuticals Holdings Ltd (PARN) for Q2 2014, worth a combined $4.76M.
Buyers outnumbered sellers: 4 funds opened new PARN positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Austin W. Marxe & David M. Greenhouse, opening a new position worth an estimated $2.39M.
- 4 institutional investors held Parnell Pharmaceuticals Holdings Ltd (PARN) as of Q2 2014, up from 0 in Q1 2014.
- Funds reported $4.76M of Parnell Pharmaceuticals Holdings Ltd stock for Q2 2014.
- 4 funds opened new Parnell Pharmaceuticals Holdings Ltd positions in Q2 2014 and 0 closed out, a net change of +4 holders.
- The largest Parnell Pharmaceuticals Holdings Ltd buyer in Q2 2014 was Austin W. Marxe & David M. Greenhouse, an estimated $2.39M added.
Based on aggregated 13F filings for Q2 2014.